Klinika RVK, UAB - financials and debts

Company age: 3 y. 3 mo.

Update

Klinika RVK - Company finances

EUR
2023
From: 2023-06-12
To: 2023-12-31
2024
From: 2024-01-01
To: 2024-12-31
2025
From: 2025-01-01
To: 2025-12-31
Financial data
Sales revenue 0 33,741 112,882
Profit before tax - - -
Net profit 0 -123,835 -113,677
Equity 1,000 -122,835 -236,544
Liabilities 17,040 230,457 325,262
Non-current assets 0 97,923 72,196
Current assets 18,040 9,699 16,522
Total assets 18,040 107,622 88,718
Taxes paid
STI taxes - 10,130 25,569
Social insurance contributions - 11,661 29,156
Financial indicators
Revenue change y/y - - +234.6%
ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. 0.0% -115.1% -128.1%
ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. 0.0% - -
Profit margin Net profit margin. Shows the overall profitability of the company. - -367.0% -100.7%
EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. - - -
Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. 17.0 - -
Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. - 2,999 4,287

Purchase full financial statements

Profit/Loss, Balance Sheet, Cash Flow, Equity

9.99 € + PVM Buy

See Scoris data in Google Search

Mark Scoris as a favorite source. One click, no registration.

Klinika RVK - Social security debts

From To Debt, €
2025-02-10 2025-02-10 108.05
2025-01-26 2025-02-02 108.05
2025-01-16 2025-01-20 108.05

Klinika RVK - VMI tax arrears

The company had no tax arrears (debts) to the State Tax Inspectorate

VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.

Analysis of the company's financial position

This description was generated by artificial intelligence. Report if inaccurate.
Klinika RVK, UAB (code 306336046) is a Private Limited Liability Company engaged in general medical practice activities. In the latest financial year, 2025, revenue increased to €112.9K from €33.7K in 2024, showing strong year-on-year growth in turnover. However, the company remained loss-making, with a net loss of €113.7K in 2025 versus €123.8K in 2024. The profit margin therefore stayed deeply negative at -100.7%, indicating that operating scale improved faster than profitability. Over the two-year period, the revenue trajectory was clearly upward, while losses improved only modestly. The balance sheet remained under pressure: equity was negative at -€236.5K in 2025, liabilities rose to €325.3K, and total assets declined to €88.7K from €107.6K a year earlier. This points to a leveraged financial position with constrained net asset value. Asset turnover reached 1.27x in 2025, and revenue per employee was €4.3K, while profit per employee was -€4.4K. Overall, the 2025 figures reflect higher business activity but still weak profitability and a strained capital structure.